Innovative Molecules Advances Adibelivir to Phase 2
29 Jan 2026 //
PR NEWSWIRE
Alfasigma Acquires Exclusive Rights To Parenteral Adibelivir
13 Jan 2026 //
PHARMIWEB
Innovative Molecules Finishes Phase 1b Trial Enrollment
16 Jun 2025 //
PR NEWSWIRE
29 Jan 2026 //
PR NEWSWIRE
13 Jan 2026 //
PHARMIWEB
16 Jun 2025 //
PR NEWSWIRE
Market Place
Sourcing Support